Sarah Silbiger/Getty Images North America/TNS
In June, the U.S. Food and Drug Administration expedited approval of a drug to treat Alzheimer’s disease, a decision that led to resignations and scrutiny of the process. 
Dr. Bob Newman, a University of Virginia Medical School graduate and U.S. Navy veteran, spent more than 15 years in private practice in rural Virginia and 20 years teaching family medicine. He teaches part-time at Eastern Virginia Medical School in Norfolk. Pfizer and Moderna have received well deserved credit for the rapid development and deployment […]
Subscribe to continue reading this article.
Already subscribed? To login in, click here.
Originally Published:
